Molecular Medicine Infrastructure
Deterministic
Molecular Medicine Infrastructure
Turn genomic and multi-omic data into governed, clinically usable intelligence for health systems, consumer genomics, payers, and pharma.
No hallucinations. No black-box clinical logic. Same input, same governed output.
<30s
Genome Resolution
1.2M+
Clinical Logic Objects
496K+
Hardy Bridge Mappings
16.8M+
Anchored Assets
Why This Matters
Genomics does not have a data problem.
It has an infrastructure problem.
Sequencing is cheap. Interpretation is not. Clinical genomics still depends on fragmented reference data, inconsistent variant calls, and opaque reasoning layers that cannot be reproduced, audited, or defended under regulatory scrutiny.
That is not a model problem. It is a substrate problem. Without deterministic resolution, anchored evidence, and governed logic, every downstream output — a report, a decision, a claim — inherits the same fragility as the data underneath it.
NomosLogic was built for the layer beneath interpretation: the infrastructure that makes molecular medicine reproducible at scale.
What Makes NomosLogic Different
Built for governed clinical and scientific use
NomosLogic resolves molecular data through anchored logic, structured evidence, and deterministic execution.
Same input, same output
Every molecular result is produced by deterministic logic — not probabilistic inference — so it is reproducible across runs, sites, and time.
Findings trace to source
Every variant, every call, every interpretation resolves to a canonical reference — ClinVar, CPIC, FDA, GWAS, Hardy Bridge — never to an opaque prior.
Logic is governed and versioned
Clinical rules are structured, immutable objects. When logic changes, prior outputs can be re-derived bit-for-bit; nothing drifts silently.
Outputs are clinically defensible
Every result carries provenance, evidence lineage, and policy state — the record required for regulatory review, payer audit, and clinician trust.
One layer, four execution domains
The same substrate serves consumer genomics, clinical genomics, payer infrastructure, and pharma research — without forking the logic underneath.
This is the difference between generating more interpretation and building infrastructure that can actually be trusted.
Platform Proof
A molecular medicine substrate, not a point solution.
NomosLogic is powered by a production-scale infrastructure layer that includes:
16.8M+
Anchored Reference Assets
1.26M+
Structured Clinical Logic Objects
496K+
Hardy Bridge Variant Mappings
362+
FDA Drug-Gene Mandates
<30s
Deterministic Genome Resolution
<90s
Multi-Omic Fusion
These are not marketing surfaces. They are the substrate that makes deterministic molecular medicine possible.
Execution Domains
One infrastructure layer. Four execution domains.
The same deterministic substrate serves every stakeholder that needs molecular data to be trustworthy, reproducible, and usable in production.
Clinical Genomics
Delivers deterministic variant interpretation, pharmacogenomic guidance, and court-defensible reporting inside the clinical workflow — with SMART on FHIR integration, full provenance, and sub-30-second genome resolution.
Consumer Genomics
Transforms existing DNA files into governed, legible, clinically relevant molecular insight. No new sequencing. No new accounts. Same genome, upgraded substrate.
Payer Infrastructure
Provides a structured evidence layer for utilization review, prior authorization, and population pharmacogenomics — grounded in FDA, CPIC, and ClinVar references rather than narrative rationale.
Pharma Research
Powers disease modeling, evolutionary resistance analysis, and trial stratification with reproducible, mechanism-anchored logic — so scientific conclusions survive re-derivation.
Engine Architecture
A deterministic engine stack built for real-world load
NomosLogic is composed of interoperable engines that resolve, map, govern, and execute molecular intelligence at scale. Each engine performs a defined role in a governed molecular medicine pipeline — from variant resolution and evidence normalization to disease modeling and clinical execution.
COVENANT
Genome Resolution Engine
28s
Resolution Time
38,324
Variants Classified
- Classifies variants into three states: Positive, Ruled Out, Uncertain
- 100% ACMG SF v3.2 secondary findings coverage
- Quality thresholds: GQ≥30, DP≥20
- Zero hallucination architecture
TRINITY
Multi-Omic Fusion Engine
<90s
Fusion Time
1.26M+
Clinical Logic Objects
- Fuses genomic variants with laboratory biomarkers under one governed schema
- Cross-references 1.26M+ structured clinical logic objects
- Pharmacogenomic recommendations with star alleles and PMID citations
- FHIR-native export to Epic and Cerner
PROTEUS
Evolutionary Discovery Engine
1,000
Benchmark Generations
130s
Benchmark Runtime
5,000
Extended Runs
16.8M+
Reference Assets
- Identifies deterministic convergence in genomic systems
- Reproduces the same constrained interaction patterns across independent runs
- In-memory execution across 16.8M+ anchored reference assets
- k-anonymity enforced directly at the SQL layer
ANCESTRAL ADAPTATION
Evolutionary Medicine Engine
8
Population Groups
496K+
Variants Screened
- Integrates evolutionary medicine directly into point-of-care logic
- gnomAD v4 population frequencies across 8 global ancestry groups
- Wright’s Fst quantifies population differentiation per variant
- Suppresses false-positive alerts from common ancestral variants
Proprietary Translation Layer
The Hardy Bridge
A proprietary nomenclature translation layer with 497,000 enriched variant-to-phenotype mappings. Translates seamlessly between clinical nomenclature systems.
Named after the architect. Impossible to replicate without licensing.
Translation at Scale
Architecture
Sovereign by Design
Data Sovereignty
Patient data never leaves the database. Clinical logic executes within the PostgreSQL query planner.
Zero-Knowledge Protocol
HIPAA compliant with salted HMAC-SHA256. Identity verification without data exposure.
SOC 2 Ready
AWS Graviton3/Nitro architecture with k-anonymity enforced at the SQL layer.
Cryptographic Audit Trail
Every clinical decision is signed and traceable. Court-defensible by design.
NomosLogic — The Operating System for Human Life
The future of molecular medicine will not be built on black-box clinical reasoning.
It will be built on deterministic infrastructure that is fast, governed, traceable, and reproducible under scrutiny. NomosLogic is building that layer.